TrialESC heart failure2018

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease.

Bertram Pitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.